DrugPatentWatch Database Preview
Drugs in Development Information for Mitoquinone
» See Plans and Pricing
What is the development status for investigational drug Mitoquinone?
Mitoquinone is an investigational drug.
There have been 7 clinical trials for Mitoquinone.
The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2007.
The most common disease conditions in clinical trials are Sclerosis, Multiple Sclerosis, and Fatigue. The leading clinical trial sponsors are Antipodean Pharmaceuticals, Inc., University of Copenhagen, and VA Office of Research and Development.
Summary for Mitoquinone
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 27 |
| WIPO Patent Applications | 9 |
| Japanese Patent Applications | 3 |
| Clinical Trial Progress | Phase 2 (2007-03-01) |
| Vendors | 7 |
Recent Clinical Trials for Mitoquinone
| Title | Sponsor | Phase |
|---|---|---|
| Mitochondrial Dysfunction and Insulin Resistance in Skeletal Muscle | University of Copenhagen | N/A |
| MitoQ for Fatigue in Multiple Sclerosis (MS) | VA Office of Research and Development | Phase 1/Phase 2 |
| MitoQ on Fatigue in Multiple Sclerosis | MitoQ Ltd | Phase 1/Phase 2 |
Clinical Trial Summary for Mitoquinone
Top disease conditions for Mitoquinone
Top clinical trial sponsors for Mitoquinone
US Patents for Mitoquinone
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
